- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Faron Pharmaceuticals Ltd.
Industry Sector: HealthTechnology
CEO: Juho Markku Jalkanen, PhD, MD
Number Of Employees: 25
Enterprise Value: $236,917,786
PE Ratio: -7.58
Exchange/Ticker 1: LSE:FARN
Exchange/Ticker 2: HSE:FARON
Latest Market Cap: $300,453,218
BioCentury | Aug 9, 2024
Management Tracks
A quintet of CFO hires at Intra-Cellular, Engrail, Faron, Coherus and Element
Plus: Sarena becomes COO of 89bio
BioCentury | Aug 7, 2024
Management Tracks
Flagship adds White House veteran Panjabi
Plus: Biogen alum Radhakrishnan joins Sofinnova Investments, and updates from Bicycle, iTeos, Fennec, Faron and ORIC
BioCentury | Jun 7, 2024
Management Tracks
Boston Pharma names Margaret Koziel CMO
Plus: Phillip Dennis joins I-Mab as CMO, and an update from Exscientia
BioCentury | Apr 16, 2024
Management Tracks
Viatris hires Corinne Le Goff as commercial head
Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | Apr 8, 2024
Management Tracks
Chi Li to lead regulatory at Curevo
Plus: Zura names Robert Lisicki as CEO, and updates from Faron, IO, PanTher and Precision
BioCentury | Sep 22, 2023
Management Tracks
Shields leaving BenevolentAI as CEO
Plus: Berns named interim CMO at Faron, and updates from Coave, Maxion, Nanoscope and Patient Square
BioCentury | Dec 1, 2022
Management Tracks
Lee to take the helm at SK Biopharmaceuticals
Plus: Amgen vet Tagari to join insitro as CSO, and updates from Haystack, Vaxxas, Akili and more
Items per page:
1 - 10 of 13